Inhibition by galloylglucose (GG6-10) of tumor invasion through extracellular matrix and gelatinase-mediated degradation of type IV collagens by metastatic tumor cells

Oncology Research

Volumn 8, Issue 12, 1996, Pages 503-511

  Ata, Naomi ^a   Oku, Tohru ^a   Hattori, Masao ^a   Fujii, Hideji ^b   Nakajima, Motowo ^c   Saiki, Ikuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NIPPON KAYAKU CO LTD   (Japan)

^c CIBA GEIGY LTD   (Switzerland)

Author keywords

galloylglucose; gelatinases; tumor invasion

Indexed keywords

COLLAGEN TYPE 4; DIMETHYL SULFOXIDE; FIBRONECTIN; GALLOYLGLUCOSE; GELATINASE; GELATINASE A; GELATINASE B; GLUCOSE DERIVATIVE; LUCIFERASE; MATRIGEL; PREDNISOLONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CELL ADHESION; CELL MIGRATION; COLLAGEN DEGRADATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROSARCOMA; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; TUMOR CELL LINE;

EID: 0030442092     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. 1. Hart, I. R. "Seed and soil" revisited: mechanisms of site specific metastasis. Cancer Metastasis Rev. 1:5-16; 1982.
2. 2. Liotta, L. A.; Rao, C. N.; Barsky, S. H. Tumor invasion and the extracellular matrix. Lab. Invest. 49:636-649; 1983.
3. 3. Fidler, I. J. The Ernst W. Bertner Memorial Award Lecture: the evolution of biological heterogeneity in metastatic neoplasms. In: Nicolson, G. L.; Milas, L., eds. Cancer invasion and metastasis: biologic and therapeutic aspects. New York: Raven Press; 1984:pp. 5-26.
4. 4. Nicolson, G. L. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res. 47:1473-1487; 1987.
5. 5. Karpathlan, S.; Pearlstein, E. Heterogeneous mechanism of tumor cell-induced platelet aggregation with possible strategy toward prevention of metastasis. In: Honn, K. V.; Sloane, B. F., eds. Hemostasis mechanisms and metastasis. Boston: Martinus Nijhoff; 1984:pp. 139-169.
6. 6. McCarthy, J. B.; Furcht, L. T. Laminin and fibronectin promote the haptotactic migration of B16-BL6 mouse melanoma cells in vitro. J. Cell Biol. 98:1474-1480; 1984.
7. 7. Terranova, V. P.; Hujanen, E. S.; Martin, G. R. Basement membrane and the invasive activity of metastatic tumor cells. J. Natl. Cancer Inst. 77:311-316; 1986.
8. 8. Matrisian, L. M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6:121-125; 1990.
9. 9. Liotta, L. A.; Steeg, P. S.; Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327-336; 1991.
10. 10. Bernhard, E. J.; Muschel, R. J.; Hughes, E. N. Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res. 50:3872-3877; 1990.
11. 11. Okada, Y.; Tsuchiya, H.; Shimizu, H.; Tomita, K.; Nakanishi, I.; Sato, H.; Seiki, M.; Yamashita, K.; Hayakawa, T. Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor-α. Biochem. Biophys. Res. Commum. 171:610-617; 1990.
12. 12. Nakajima, M.; Welch, D. R.; Belloni, P. N.; Nicolson, G. L. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res. 47:4869-4876; 1987.
13. 13. Liotta, L. A.; Stetler-Stevenson, W. Metalloproteinases and malignant conversion: does correlation imply causality? J. Natl. Cancer Inst. 81:556-557; 1989.
14. 14. Ura, H.; Bonfil, D.; Reich, R.; Reddel, R.; Pfeifer, A.; Harris, C. C. Expression of type IV collagenase and procollagenase genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res. 49:4615-4621; 1989.
15. 15. Liotta, L. A. Cancer cell invasion and metastasis. Sci. Am. 266:34-41; 1992.
16. 16. Davis, B.; Miles, D. W.; Happerfield, L. C.; Naylor, M. S.; Bobrow, L. G.; Rubens, R. D.; Balkwill, F. R.; Activity of type IV collagenases in benign and malignant breast diseases. Br. J. Cancer 67:1126-1131; 1993.
17. 17. Boag, A. H.; Young, I. D. Increased expression of the 72 kd type IV collagenase in prostatic adenocarcinoma. Demonstration by immunohistochemistry and in situ hybridization. Am. J. Pathol. 144:585-591; 1994.
18. 18. Davies, B.; Waxman, J.; Wasan, H.; Abel, P.; Williams, G.; Krausz, T.; Neal, D.; Thomas, D.; Hanby, A.; Balkwill, F. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res. 53:5365-5369; 1993.
19. 19. Autio-Harmainen, H.; Karttunen, T.; Hurskainen, T.; Hoyhtya, M.; Kauppila, A.; Tryggvason, K. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors. Lab. Invest. 69: 312-321; 1993.
20. 20. Nishizawa, M.; Yamagishi, T.; Nonaka, G.; Nishioka, I. Structure of gallotannins in Paeoniae Radix. Chem. Pharm. Bull. 28:2850-2852; 1980.
21. 21. Kakiuchi, N.; Hattori, M.; Nishizawa, M.; Yamagishi, T.; Okuda, T.; Namba, T. Studies on dental caries prevention by traditional medicines. VIII. Inhibitory effect of various tannins on glucan synthesis by glucosyltransferase from Streptococcus mutans. Chem. Pharm. Bull. 34:720-725; 1986.
22. 22. Nishizawa, M.; Yamagishi, T.; Ohyama, T. Inhibitory effect of gallotannins on the respiration of rat liver mitochondria. Chem. Pharm. Bull. 31:2150-2152; 1983.
23. 23. Saiki, I.; Murata, J.; Nakajima, M.; Tokura, S.; Azuma, I. Inhibition by sulfated chitin derivatives of invasion through extracellular matrix and enzymatic degradation by metastatic melanoma cells. Cancer Res. 50: 3631-3637; 1990.
24. 24. Saiki, I.; Murata, J.; Watanabe, K.; Fujii, H.; Abe, F.; Azuma, I. Inhibition of tumor cell invasion by Ubenimex (Bestatin) in vitro. Jpn. J. Cancer Res. 80:873-878; 1989.
25. 25. Komazawa, H.; Saiki, I.; Aoki, M.; Kitaguchi, H.; Satoh, H.; Kojima, M.; Ono, M.; Itoh, I.; Azuma, I. Synthetic Arg-Gly-Asp-Ser analogues of the cell recognition site of fibronectin that retain antimetastatic and anticell adhesive properties. Biol. Pharm. Bull. 16:997-1003; 1993.
26. 26. Sato, H.; Kida, Y.; Mai, M.; Endo, Y.; Sasaki, T.; Tanaka, J.; Seiki, M. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 7:77-83; 1992.
27. 27. Chua, C. C.; Geiman, D. E.; Keller, G. H.; Ladda, R. L. Induction of collagenase secretion in human fibroblast cultures by growth promoting factors. J. Biol. Chem. 260:5213-5216; 1985.
28. 28. Dayer, J.-M.; Beutler, B.; Cerami, A. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162:2163-2168; 1985.
29. 29. Edwards, D. R.; Murphy, G.; Reynolds, J. J.; Whitham, S. E.; Docherty, A. J. P.; Angel, P.; Heath, J. K. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6:1899-1904; 1987.
30. 30. Sato, H.; Kita, M.; Seiki, M. v-Src activates the expression of 92-kDa Type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. J. Biol. Chem. 268:23460-23468; 1993.
31. 31. Poole, A. R.; Titman, K. J.; Recklies, A. D.; Stoker, T. A. Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinoma and fibroadenomas. Nature 273:545-547; 1978.
32. 32. Recklies, A. D.; Mort, J. S.; Poole, A. R. Secretion of a thiol proteinase from mouse mammary carcinomas and its characterization. Cancer Res. 42:1026-1032; 1982.
33. 33. Robertson, D. M.; Williams, D. C. In vitro evidence for neutral collagenase activity in an invasive mammalian tumor. Nature 221:259-260; 1969.
34. 34. Dano, K.; Andreasen, P. A.; Grondahl-Hansen, J.; Kristensen, P.; Nielsen, L. S.; Skriver, L. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44:139-266; 1985.
35. 35. Matrisian, L. M.; Leroy, P.; Ruhlmann, C.; Gesnel, M.-C.; Breathnach, R.; Isolation of the oncogene and epidermal growth factor-induced transin gene: complex control in rat fibroblasts. Mol. Cell. Biol. 6:1679-1686; 1986.
36. 36. Nicholson, R. C.; Mader, S.; Nagpal, S.; Leid, M.; Rochette-Egly, C.; Chambon, P. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. EMBO J. 9: 4443-4454; 1990.
37. 37. Sato, H.; Seiki, M. Regulatory mechanism of 92kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8:395-405; 1993.